These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 24292963)

  • 1. A personalized treatment for lung cancer: molecular pathways, targeted therapies, and genomic characterization.
    Hensing T; Chawla A; Batra R; Salgia R
    Adv Exp Med Biol; 2014; 799():85-117. PubMed ID: 24292963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted therapies for small cell lung cancer: Where do we stand?
    Arcaro A
    Crit Rev Oncol Hematol; 2015 Aug; 95(2):154-64. PubMed ID: 25800975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological and genomic comparisons between different histologic components in combined small cell lung cancer and non-small cell lung cancer.
    Lin MW; Su KY; Su TJ; Chang CC; Lin JW; Lee YH; Yu SL; Chen JS; Hsieh MS
    Lung Cancer; 2018 Nov; 125():282-290. PubMed ID: 30429033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Therapy for Non-Small Cell Lung Cancer.
    Noor ZS; Cummings AL; Johnson MM; Spiegel ML; Goldman JW
    Semin Respir Crit Care Med; 2020 Jun; 41(3):409-434. PubMed ID: 32450595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer.
    Wen S; Dai L; Wang L; Wang W; Wu D; Wang K; He Z; Wang A; Chen H; Zhang P; Dong X; Dong YA; Wang K; Yao M; Wang M
    Oncologist; 2019 Nov; 24(11):e1070-e1081. PubMed ID: 30902917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer.
    Niederst MJ; Sequist LV; Poirier JT; Mermel CH; Lockerman EL; Garcia AR; Katayama R; Costa C; Ross KN; Moran T; Howe E; Fulton LE; Mulvey HE; Bernardo LA; Mohamoud F; Miyoshi N; VanderLaan PA; Costa DB; Jänne PA; Borger DR; Ramaswamy S; Shioda T; Iafrate AJ; Getz G; Rudin CM; Mino-Kenudson M; Engelman JA
    Nat Commun; 2015 Mar; 6():6377. PubMed ID: 25758528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized targeted therapy for lung cancer.
    Wu K; House L; Liu W; Cho WCS
    Int J Mol Sci; 2012; 13(9):11471-11496. PubMed ID: 23109866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and sequence complexity of anaplastic lymphoma kinase gene fusions in Chinese lung cancer patients.
    Tian HX; Zhang XC; Yang JJ; Guo WB; Chen ZH; Wang Z; Wu YL
    Lung Cancer; 2017 Dec; 114():90-95. PubMed ID: 29173772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkers.
    Fichtner I; Rolff J; Soong R; Hoffmann J; Hammer S; Sommer A; Becker M; Merk J
    Clin Cancer Res; 2008 Oct; 14(20):6456-68. PubMed ID: 18927285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized therapy on the horizon for squamous cell carcinoma of the lung.
    Kim HS; Mitsudomi T; Soo RA; Cho BC
    Lung Cancer; 2013 Jun; 80(3):249-55. PubMed ID: 23489560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalizing therapy in advanced non-small cell lung cancer.
    Villaruz LC; Burns TF; Ramfidis VS; Socinski MA
    Semin Respir Crit Care Med; 2013 Dec; 34(6):822-36. PubMed ID: 24258572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets.
    Rekhtman N; Pietanza MC; Hellmann MD; Naidoo J; Arora A; Won H; Halpenny DF; Wang H; Tian SK; Litvak AM; Paik PK; Drilon AE; Socci N; Poirier JT; Shen R; Berger MF; Moreira AL; Travis WD; Rudin CM; Ladanyi M
    Clin Cancer Res; 2016 Jul; 22(14):3618-29. PubMed ID: 26960398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies.
    Li T; Kung HJ; Mack PC; Gandara DR
    J Clin Oncol; 2013 Mar; 31(8):1039-49. PubMed ID: 23401433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular characteristics of lung cancer].
    Bernaudin JF
    Bull Cancer; 2010 Nov; 97(11):1323-35. PubMed ID: 21051316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive molecular analysis of driver mutations in non-small cell lung carcinomas and its correlation with PD-L1 expression, An Indian perspective.
    Aggarwal A; Sharma S; Brar Z; Kumar V; Kumar A; Katara R; Mohanty SK
    Pathol Res Pract; 2024 Jan; 253():155013. PubMed ID: 38096714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personalized Therapy of Small Cell Lung Cancer.
    Schneider BJ; Kalemkerian GP
    Adv Exp Med Biol; 2016; 890():149-74. PubMed ID: 26703804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A decade of advances in treatment for advanced non-small cell lung cancer.
    Gettinger S; Lynch T
    Clin Chest Med; 2011 Dec; 32(4):839-51. PubMed ID: 22054890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining genomic alteration boundaries for a combined small cell and non-small cell lung carcinoma.
    Buys TP; Aviel-Ronen S; Waddell TK; Lam WL; Tsao MS
    J Thorac Oncol; 2009 Feb; 4(2):227-39. PubMed ID: 19179901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiplex genomic test of mutation and fusion genes in small biopsy specimen of lung cancer.
    Oshita F; Kasajima R; Miyagi Y
    J Exp Ther Oncol; 2016 Jul; 11(3):189-194. PubMed ID: 28471124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in molecular-based personalized non-small-cell lung cancer therapy: targeting epidermal growth factor receptor and mechanisms of resistance.
    Jotte RM; Spigel DR
    Cancer Med; 2015 Nov; 4(11):1621-32. PubMed ID: 26310719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.